HARDY ALEXANDER (Chief Executive Officer) reported 1 transaction at BIOMARIN PHARMACEUTICAL INC
Review the transaction codes below to understand the nature of each event.
Filed: 3/19/2026ACC: 0001628280-26-019847
DirectorOfficer· Chief Executive Officer
Since Dec 2023
-4.25K
Net shares
Net seller
$238.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.25K
Price / share
$56.05
Trade value
$238.32K
% of position
1.9%
3/17/2026
218.89K→214.63K
Total
Net shares
−4.25K
Net value
-$238.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | F · Tax Withholding | −4.25K | $56.05 | $238.32K | 1.9% | 218.89K | 214.63K |
| Total | −4.25K | -$238.32K | ||||||
Derivative Transactions0
No derivative transactions reported